8-K ·Filed Oct 16, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Routine board addition with no financial or strategic catalyst. Monitor for any subsequent material agreements or changes in corporate strategy that may signal a shift in direction.
Latest settled — T+5d
CHGA ▲ +7.01% at T+5d
NEUTRAL call +7.01% · α vs SPY +6.91% · entry $1.57 → $1.68
T+1d
-14.65%
call -14.65% · α -15.07%
$1.34
settled 8d ago
T+5d
+7.01%
call +7.01% · α +6.91%
$1.68
settled 4d ago
T+20d
Pending
in 17d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
Change Agents Corporation appointed Eric Weisblum as an independent director and committee member, effective October 12, 2026. This is a routine board appointment with no financial terms disclosed, carrying no material impact on operations or stock.
Key Facts
- Eric Weisblum appointed as independent director effective October 12, 2026
- Will serve on Audit, Compensation, and Nominating and Corporate Governance Committees
- Weisblum is CEO of Silo Pharma Inc and has investment banking and capital markets experience
- No arrangement or understanding with any person other than directors for his selection
- No related-party transactions disclosed under Item 404(a)
Financial Impact
No financial impact; no compensation or financial terms disclosed
Risk Factors
- No material risks identified from this filing
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-110039 |
| Document: 0001213900-26-110039-index-headers.html | 0001213900-26-110039 |
| Document: 0001213900-26-110039-index.html | 0001213900-26-110039 |
| Document: 0001213900-26-110039.txt | 0001213900-26-110039 |
8 reports for CHGA
75% Hit rate @ T+20 Went positive at some point 4 of 6 best @ T+60▲ +71.55%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 8-K | $1.40 | awaiting T+20 | — | $1.65 (−17.86%) |
Oct 16, 2026 10d ago | 8-K | $1.57 | awaiting T+20 | — | $1.65 (+5.10%) |
Sep 29, 2026 27d ago | DEF 14A | $1.96 | awaiting T+20 | — | $1.65 (+15.82%) |
Sep 21, 2026 5w ago | EFFECT | $2.06 $1.34 | ▲ +34.95% | ▲ +34.04% | $1.65 (+19.90%) |
Sep 16, 2026 5w ago | S-1/A | $2.04 $1.71 | ▲ +15.97% | ▲ +17.18% | $1.65 (+18.92%) |
Sep 14, 2026 6w ago | 8-K | $1.98 $2.02 | ▼ −2.02% | ▲ +0.70% | $1.65 (+16.67%) |
Aug 31, 2026 8w ago | 8-K | $2.89 $1.96 | ▼ −32.18% | ▼ −31.99% | $1.65 (−42.91%) |
Jul 23, 2026 13w ago | 8-K | $0.2355 $0.1695 | ▲ +28.03% | ▲ +31.65% | $1.65 (−600.64%) |
Showing 8 of 8
US Market Status
Market Closed — Opens Wed (12h 40m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers